Press Release ImmVira Reports 100% Complete Response Rate at 9 Months in Bladder Carcinoma in Situ with MVR-T3011 at ASCO 1 June 2026
Press Release TiumBio to Present Phase 2a Interim Data Highlighting Differentiated Clinical Profile for Tosposertib(TU2218) plus Pembrolizumab in First-Line R/M HNSCC at ASCO 2026 31 May 2026
Press Release Scripps Pulls 54 Local Stations from DIRECTV After Seeking Record Retransmission Consent Rates 31 May 2026
Press Release Web3 Has No Safe AI. DMind AI Just Quantified the Gap — and KDD 2026 Made It Official. 31 May 2026
Press Release Berkshire Hathaway to Acquire Taylor Morrison Home Corporation for $8.5 Billion 31 May 2026
Press Release Government of Canada invests in school food data and research to help improve school food programs across Canada 31 May 2026
Press Release iHuman Inc. Announces Acquisition of Businesses and Assets Related to All Knowledge and Perfect Lingo 31 May 2026
Press Release Dizal Presents Positive NSCLC Data for Fourth-Generation EGFR TKI DZD6008 and Golidocitinib in Combination with Anti-PD-1 at ASCO 2026 31 May 2026
Press Release Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC Published in The Lancet 31 May 2026
